EXHLS — ExHeaLifeSpan

Precision Aging Intelligence

Aging measured.
Not estimated.

EXHLS uses proprietary breath-to-droplet FTIR spectrometry and multimodal AI to deliver a continuous biological age score — replacing episodic guesswork with longitudinal precision intelligence.

Proprietary Platform

100× sensitivity. One feedback loop.

Breath biomarkers, cognitive testing, bloodwork, microbiome, DNA risk, and continuous wearable signals — unified into a single multimodal aging model.

  • Breath-to-Droplet FTIR Spectrometry
  • Multimodal AI Aging Model
  • Cognitive & Neurological Assessment
  • Microbiome & Genomic Integration
  • Continuous Wearable Intelligence

The Market Opportunity

Aging is the largest unclaimed market in healthcare.

Global longevity market by 2030Fastest-growing segment in healthcare
$610B
Incumbent precision aging platformsNo operating system for biological age exists yet
0
Sensitivity advantage over conventional FTIRProprietary breath-to-droplet spectrometry
100×

Business Model

Layered revenue. Compounding defensibility.

Three interlocking revenue streams — each reinforcing the others — create a platform with compounding data advantages and structural moats.

Consumer

Direct-to-consumer longevity programs — breath testing, biomarker analysis, and AI-driven health scores.

Key Features

  • Breath-based biological age score
  • Multimodal biomarker panel
  • Cognitive & neurological assessment
  • Personalized longevity program

Enterprise

Platform licensing for health systems, insurers, and longevity clinics — deployed at scale.

Key Features

  • White-label platform deployment
  • Population aging analytics
  • EHR & wearable integration
  • Enterprise API access

Research

Longitudinal cohort data and clinical research partnerships — the dataset that defines the field.

Key Features

  • Anonymized longitudinal cohorts
  • Biomarker research datasets
  • Clinical trial infrastructure
  • Pharma & academic licensing

All revenue streams operate in parallel, with each layer generating proprietary data that compounds the value of the others.

Request a Briefing

Biological age is the most important number in healthcare — and no one is measuring it continuously. EXHLS is building that infrastructure.

EXHLSInvestment Thesis · 2026

Why Now

Longevity demandConsumers spending on measurable health optimization at scale
AI viabilityMultimodal biological modeling is now commercially deployable
No incumbentZero operating systems for continuous biological age exist today
EXHLS — ExHeaLifeSpan
© 2026 EXHLS. All rights reserved.Precision Aging Intelligence